Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReINFORCE: Clemastine Fumarate for Myelin Repair in Acute Demyelinating Lesions
NCT06065670Phase 2Not yet recruiting
- Sponsor
- University of California, San Francisco
- Start
- Sep 2026
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clemastine in multiple sclerosis (MS), sponsored by University of California, San Francisco. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
clemastine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT06065670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06065670.